Japan's Astellas Pharma <a href="https://www.reuters.com/companies/4503.T" target="_blank">(4503.T)</a> said on Monday it agreed to buy U.S. drugmaker Iveric Bio Inc for about $5.9 billion in its biggest acquisition, giving it access to a range of ophthalmolo…